Sanofi readies to meet US demand for RSV antibody

Sanofi readies to meet US demand for RSV antibody

Source: 
BioPharma Dive
snippet: 

After supply constraints last year, Sanofi and partner AstraZeneca have secured regulatory clearance for a new manufacturing line for their drug Beyfortus.